220 related articles for article (PubMed ID: 34552928)
1. Construction and Validation of a Novel Immunosignature for Overall Survival in Uveal Melanoma.
Gu C; Gu X; Wang Y; Yao Z; Zhou C
Front Cell Dev Biol; 2021; 9():710558. PubMed ID: 34552928
[TBL] [Abstract][Full Text] [Related]
2. A Comprehensive Prognostic and Immunological Analysis of a Six-Gene Signature Associated With Glycolysis and Immune Response in Uveal Melanoma.
Liu J; Lu J; Li W
Front Immunol; 2021; 12():738068. PubMed ID: 34630418
[TBL] [Abstract][Full Text] [Related]
3. Immunogenic profiling of metastatic uveal melanoma discerns a potential signature related to prognosis.
Wang J; Liu M; Sun J; Zhang Z
J Cancer Res Clin Oncol; 2024 Jan; 150(1):23. PubMed ID: 38246894
[TBL] [Abstract][Full Text] [Related]
4. Construction and validation of a novel prognostic signature for uveal melanoma based on five metabolism-related genes.
Zhao H; Chen Y; Shen P; Gong L
Math Biosci Eng; 2021 Sep; 18(6):8045-8063. PubMed ID: 34814288
[TBL] [Abstract][Full Text] [Related]
5. Identification and validation of a CCL18-related signature for prediction of overall survival in patients with uveal melanoma.
Yang B; Fan Y; Chen M; Tang L; Tang X; Li H; Gu A; Liang R; Wu Y
Exp Eye Res; 2023 May; 230():109448. PubMed ID: 36967081
[TBL] [Abstract][Full Text] [Related]
6. Identification of Survival-Related Metabolic Genes and a Novel Gene Signature Predicting the Overall Survival for Patients with Uveal Melanoma.
Guo X; Yu X; Li F; Xia Q; Ren H; Chen Z; Xing Y
Ophthalmic Res; 2022; 65(5):516-528. PubMed ID: 35390784
[TBL] [Abstract][Full Text] [Related]
7. An autophagy-related prognostic signature associated with immune microenvironment features of uveal melanoma.
Zheng Z; Zhang L; Tu Z; Deng Y; Yin X
Biosci Rep; 2021 Mar; 41(3):. PubMed ID: 33682883
[TBL] [Abstract][Full Text] [Related]
8. Identification and validation of tumor microenvironment-related lncRNA prognostic signature for uveal melanoma.
Liao CL; Hu N; Sun XY; Zhou Q; Tian M; Cao Y; Lyu HB
Int J Ophthalmol; 2021; 14(8):1151-1159. PubMed ID: 34414077
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of immunogenic cell death-related signature for predicting the prognosis and immune landscape of uveal melanoma.
Hu Y; Cai J; Ye M; Mou Q; Zhao B; Sun Q; Lou X; Zhang H; Zhao Y
Front Immunol; 2022; 13():1037128. PubMed ID: 36466923
[TBL] [Abstract][Full Text] [Related]
10. Identification of a novel immune-related gene signature for prognosis and the tumor microenvironment in patients with uveal melanoma combining single-cell and bulk sequencing data.
Wang W; Zhao H; Wang S
Front Immunol; 2023; 14():1099071. PubMed ID: 36793711
[TBL] [Abstract][Full Text] [Related]
11. Construction and validation of a pyroptosis-related gene signature associated with the tumor microenvironment in uveal melanoma.
Zhang F; Deng Y; Wang D; Wang S
Sci Rep; 2022 Jan; 12(1):1640. PubMed ID: 35102195
[TBL] [Abstract][Full Text] [Related]
12. Integrative analysis identifies key genes related to metastasis and a robust gene-based prognostic signature in uveal melanoma.
Lei S; Zhang Y
BMC Med Genomics; 2022 Mar; 15(1):61. PubMed ID: 35300699
[TBL] [Abstract][Full Text] [Related]
13. Integrative analyses of a mitophagy-related gene signature for predicting prognosis in patients with uveal melanoma.
Cheng Y; Liu J; Fan H; Liu K; Zou H; You Z
Front Genet; 2022; 13():1050341. PubMed ID: 36544483
[TBL] [Abstract][Full Text] [Related]
14. Identification of survival-related genes and a novel gene-based prognostic signature involving the tumor microenvironment of uveal melanoma.
Lei S; Zhang Y
Int Immunopharmacol; 2021 Jul; 96():107816. PubMed ID: 34162166
[TBL] [Abstract][Full Text] [Related]
15.
Meng Z; Chen Y; Wu W; Yan B; Zhang L; Chen H; Meng Y; Liang Y; Yao X; Luo J
Front Immunol; 2022; 13():754645. PubMed ID: 35281030
[TBL] [Abstract][Full Text] [Related]
16. Tumor subtypes and signature model construction based on chromatin regulators for better prediction of prognosis in uveal melanoma.
Li Y; Xiong C; Wu LL; Zhang BY; Wu S; Chen YF; Xu QH; Liao HF
Pathol Oncol Res; 2023; 29():1610980. PubMed ID: 37362244
[No Abstract] [Full Text] [Related]
17. A Novel Ferroptosis-Associated Gene Signature to Predict Prognosis in Patients with Uveal Melanoma.
Luo H; Ma C
Diagnostics (Basel); 2021 Feb; 11(2):. PubMed ID: 33540700
[TBL] [Abstract][Full Text] [Related]
18. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
[TBL] [Abstract][Full Text] [Related]
19. Development and Validation of a Novel Metabolic Signature-Based Prognostic Model for Uveal Melanoma.
Shi K; Li X; Zhang J; Sun X
Transl Vis Sci Technol; 2022 May; 11(5):9. PubMed ID: 35536719
[TBL] [Abstract][Full Text] [Related]
20. Identification of Prognostic Glycolysis-Related lncRNA Signature in Tumor Immune Microenvironment of Hepatocellular Carcinoma.
Bai Y; Lin H; Chen J; Wu Y; Yu S
Front Mol Biosci; 2021; 8():645084. PubMed ID: 33968985
[No Abstract] [Full Text] [Related]
[Next] [New Search]
